The Cox regression model showed that regardless of p16Ink4a status, the age of the patient, the sex, and the Karnosky score, an enriched NRF2 target gene score predicted worse survival in patients with GBM (Fig. 7g; Supplementary Data 4). The gene discussed is CDKN2A; the disease is glioblastoma.